Literature DB >> 11739123

Mesangial cell filamentous actin disassembly and hypocontractility in high glucose are mediated by PKC-zeta.

John A Dlugosz1, Snezana Munk, Eric Ispanovic, Howard J Goldberg, Catharine I Whiteside.   

Abstract

In high glucose (HG), mesangial cells (MCs) lose their contractile response to endothelin-1 (ET-1) coincidently with filamentous (F)-actin disassembly. We postulated that these MC phenotypic changes are mediated by altered protein kinase C (PKC) isozyme activity, myosin light chain (MLC(20)) phosphorylation, or Ca(2+) signaling. MCs were growth arrested for 24 h in 0.5% fetal bovine serum (FBS)-DMEM in 5.6 (normal glucose; NG) or 30 mM glucose (high glucose; HG). In HG, the planar area was reduced [2,608 +/- 135 vs. 3,952 +/- 225 (SE) microm(2) in NG, P < 0.01, n = 31] with no contractile response to 0.1 microM ET-1. Mannitol did not affect cell size or ET-1 response. Confocal imaging of fluo 3- loaded cells revealed that the peak intensity of ET-1-induced Ca(2+) signaling was not altered in HG vs. NG. Immunoblotting of phosphorylated MLC(20) showed that HG increased mono- and decreased unphosphorylated MLC(20) (42 +/- 16 and 49 +/- 15 vs. 13 +/- 3 and 80 +/- 4% of total in NG, P < 0.05, n = 3), but the peak phosphorylation responses to ET-1 were identical in NG and HG. ET-1 stimulated translocation of PKC-delta and -epsilon from cytosolic to membrane and particulate fractions identically in NG and HG but did not cause PKC-zeta translocation. In HG, membrane accumulation of PKC-zeta was observed. Membrane PKC-zeta activity measured by immunoprecipitation and (32)P phosphorylation of PKC-epsilon pseudosubstrate peptide was 190 +/- 18% of NG (P < 0.01, n = 4), which was completely inhibited by pretreatment with a myristoylated peptide inhibitor (ZI). In HG, pretreatment with ZI for 24 h restored normal MC size and contractile and F-actin disassembly responses to ET-1. In conclusion, in HG, decreased MC size is due to decreased F-actin assembly, and loss of contractile response to ET-1 occurs in the presence of normal Ca(2+) signaling and normal MLC(20) phosphorylation. In HG, altered F-actin and contractile functions in MCs are mediated by PKC-zeta.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11739123     DOI: 10.1152/ajprenal.0055.2001

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  6 in total

1.  Short-term high-glucose treatment decreased abundance of Orai1 protein through posttranslational mechanisms in rat mesangial cells.

Authors:  Hui Jiang; Shubiao Zou; Sarika Chaudhari; Rong Ma
Journal:  Am J Physiol Renal Physiol       Date:  2018-01-24

2.  Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?

Authors:  Roger M Mason
Journal:  J Cell Commun Signal       Date:  2009-02-14       Impact factor: 5.782

3.  PKCdelta regulates the stimulation of vascular endothelial factor mRNA translation by angiotensin II through hnRNP K.

Authors:  Kavithalakshmi Sataranatarajan; Myung-Ja Lee; Meenalakshmi M Mariappan; Denis Feliers
Journal:  Cell Signal       Date:  2008-02-01       Impact factor: 4.315

4.  Increased renal gene transcription of protein kinase C-beta in human diabetic nephropathy: relationship to long-term glycaemic control.

Authors:  R G Langham; D J Kelly; R M Gow; Y Zhang; A J Cox; W Qi; K Thai; C A Pollock; P K Christensen; H-H Parving; R E Gilbert
Journal:  Diabetologia       Date:  2008-02-16       Impact factor: 10.122

5.  Protein kinase C-zeta regulation of GLUT4 translocation through actin remodeling in CHO cells.

Authors:  Xiao-Jun Liu; Chang Yang; Nishith Gupta; Jin Zuo; Yong-Sheng Chang; Fu-De Fang
Journal:  J Mol Med (Berl)       Date:  2007-07-10       Impact factor: 4.599

Review 6.  Molecular mechanisms of diabetic vascular complications.

Authors:  Munehiro Kitada; Zhaoyun Zhang; Akira Mima; George L King
Journal:  J Diabetes Investig       Date:  2010-06-01       Impact factor: 4.232

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.